Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Unresectable and Advanced Cholangiocarcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT01859182
What this trial is testing

Selumetinib and Akt Inhibitor MK-2206 in Treating Patients With Refractory or Advanced Gallbladder or Bile Duct Cancer That Cannot Be Removed By Surgery

Who this might be right for
Adenocarcinoma of the GallbladderAdenocarcinoma With Squamous Metaplasia of the GallbladderAdult Primary Cholangiocellular Carcinoma+12 more
National Cancer Institute (NCI)
Not applicableLooking for participantsNCT06140134
What this trial is testing

Liver Transplantation in Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic CholangiocarcinomaCholangiocarcinoma, Intrahepatic
Rutgers, The State University of New Jersey 30
Testing effectiveness (Phase 2)Study completedNCT01425879
What this trial is testing

MK2206 in Treating Patients With Advanced Refractory Biliary Cancer That Cannot Be Removed by Surgery

Who this might be right for
Advanced Adult Hepatocellular CarcinomaLocalized Non-Resectable Adult Liver CarcinomaRecurrent Adult Liver Carcinoma+5 more
National Cancer Institute (NCI) 8
Large-scale testing (Phase 3)Study completedNCT04924062
What this trial is testing

Pembrolizumab (MK-3475) Plus Gemcitabine/Cisplatin Versus Placebo Plus Gemcitabine/Cisplatin for First-Line Advanced and/or Unresectable Biliary Tract Carcinoma (BTC) (MK-3475-966/KEYNOTE-966)-China Extension Study

Who this might be right for
Biliary Tract Carcinoma
Merck Sharp & Dohme LLC 158
Testing effectiveness (Phase 2)UnknownNCT05978609
What this trial is testing

Cadonilimab With Chemotherapy in Treating Advanced Biliary Cancer

Who this might be right for
Cholangiocarcinoma Non-resectable
West China Hospital 65
Testing effectiveness (Phase 2)Study completedNCT00101036
What this trial is testing

Lapatinib in Treating Patients With Locally Advanced or Metastatic Biliary Tract or Liver Cancer That Cannot Be Removed By Surgery

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+5 more
National Cancer Institute (NCI) 57
Early research (Phase 1)Study completedNCT00486356
What this trial is testing

Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerGastric Cancer+2 more
University of Nebraska 46
Testing effectiveness (Phase 2)UnknownNCT05991518
What this trial is testing

IAH0968 in Combination With GC for the Treatment of HER2-Positive Unresectable Advanced/Metastatic Malignant Tumors

Who this might be right for
HER2 Gene Mutation
SUNHO（China）BioPharmaceutical CO., Ltd. 136
Testing effectiveness (Phase 2)Study completedNCT04238715
What this trial is testing

E7090 in Participants With Unresectable Advanced or Metastatic Cholangiocarcinoma With Fibroblast Growth Factor Receptor (FGFR) 2 Gene Fusion

Who this might be right for
Cholangiocarcinoma
Eisai Co., Ltd. 63
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06855225
What this trial is testing

A Phase II Study of Single Tremelimumab With Regular Interval Durvalumab Plus Gemcitabine and Cisplatin in Locally Advanced Unresectable/Metastatic Combined Hepatocellular-cholangiocarcinoma

Who this might be right for
Combined Hepatocellular and Cholangiocarcinoma
Mehmet Akce 29
Testing effectiveness (Phase 2)Study completedNCT00073905
What this trial is testing

Adjuvant Palliative Capecitabine and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Biliary Tract Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerLiver Cancer+1 more
Swiss Cancer Institute 44
Testing effectiveness (Phase 2)Study completedNCT02520141
What this trial is testing

Ramucirumab in Treating Patients With Advanced or Metastatic, Previously Treated Biliary Cancers That Cannot Be Removed by Surgery

Who this might be right for
CholangiocarcinomaLiver and Intrahepatic Bile Duct CarcinomaStage III Gallbladder Cancer AJCC v7+9 more
M.D. Anderson Cancer Center 61
Not applicableStudy completedNCT00253383
What this trial is testing

Early Intervention vs. Standard Palliative Care in Improving End-of-Life Care in Advanced Cancer Patients

Who this might be right for
Cancer
Dartmouth-Hitchcock Medical Center 329
Early research (Phase 1)Ended earlyNCT01525069
What this trial is testing

Hepatic Arterial Infusion in Treating Patients With Locally Advanced, Non-Metastatic Cholangiocarcinoma

Who this might be right for
CholangiocarcinomaLiver Neoplasms
Washington University School of Medicine 27
Early research (Phase 1)Study completedNCT00003411
What this trial is testing

Radiation Therapy in Treating Patients With Bile Duct, Gallbladder, or Pancreatic Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerPancreatic Cancer
University of Pittsburgh
Early research (Phase 1)Study completedNCT04676633
What this trial is testing

Safety, Tolerability, PK, Anti-Tumor Activity of STP705 in Subjects With Advanced/Metastatic or Surgically Unresectable Solid Tumors Who Are Refractory to Standard Therapy

Who this might be right for
Hepatocellular CarcinomaLiver MetastasesCholangiocarcinoma
Sirnaomics 5
Testing effectiveness (Phase 2)Study completedNCT04256980
What this trial is testing

Pemigatinib in Treating Patients With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Including FGFR2 Rearrangement

Who this might be right for
Cholangiocarcinoma
Innovent Biologics (Suzhou) Co. Ltd. 34
Testing effectiveness (Phase 2)UnknownNCT00010088
What this trial is testing

Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas or Bile Duct

Who this might be right for
Extrahepatic Bile Duct CancerPancreatic Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group
Early research (Phase 1)Study completedNCT01643499
What this trial is testing

Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies

Who this might be right for
Acinar Cell Adenocarcinoma of the PancreasAdenocarcinoma of the GallbladderAdenocarcinoma of Unknown Primary+37 more
University of Chicago 79
Testing effectiveness (Phase 2)Study completedNCT02042443
What this trial is testing

Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by Surgery

Who this might be right for
Adult CholangiocarcinomaAdvanced Adult Hepatocellular CarcinomaBCLC Stage C Adult Hepatocellular Carcinoma+16 more
National Cancer Institute (NCI) 53
Next Page